IQVIA Holdings Inc. (IQV) stock analysis
Close on Nov 12, 2026Market cap $44.68BP/E 32.9Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Weak7 of 30 checks passed
Iqvia passes 7 of the 30 checks behind our score; 5 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 3/6
- Past performance
- 4/6
- Financial health
- 0/6
- Dividend
- 0/6
What stands out
Return on equity over 15%
Return on equity was 21.7% over the last twelve months and averaged 20.3% over five years.
Earnings grew over 5 years
Net income grew 37.3% a year on average over the last five fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 11.1% a year over the last three fiscal years.
Guidance raised
Iqvia raised its full-year 2026 revenue outlook on Jul 28, 2026.
What to watch
Margin of safety under 20%
The price is 24.8% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $274.53 is above our fair value estimate of $219.95.
Return on capital under 10%
Return on invested capital was 9.4%, below the 10% that usually covers the cost of capital.
High debt
Debt is 241% of shareholders' equity, above the 40% we consider low.
Valuation0/6
P/E above its 5-year median
Iqvia's P/E of 33.4 is above its own 5-year median of 32.6.
P/E above the industry
Iqvia's P/E of 33.4 is above the Engineering, Accounting, Research, Management, and Related Services median of 25.2.
EV/EBITDA above its 5-year median
Iqvia's EV/EBITDA of 17.2 is above its 5-year median of 16.8.
P/B above the industry
Iqvia's price-to-book of 6.79 is above the Engineering, Accounting, Research, Management, and Related Services median of 3.70.
Trading above fair value
The share price of $274.53 is above our fair value estimate of $219.95.
Margin of safety under 20%
The price is 24.8% above fair value, so there is no margin of safety.
Growth3/6
Revenue growing under 10% a year
Revenue grew 4.2% a year over the last three fiscal years, short of the 10% we look for.
EPS growing 10%+ a year
Diluted EPS grew 11.1% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew 8.7% over the last twelve months, against a 5-year average of 37.3% a year.
Growing faster than the industry
Revenue grew 8.8% over the last twelve months; the Engineering, Accounting, Research, Management, and Related Services median is 6.6%.
Guidance raised
Iqvia raised its full-year 2026 revenue outlook on Jul 28, 2026.
Gross margin slipping
Gross margin was 33.1% over the last twelve months, against 33.8% a year earlier.
Past performance4/6
Return on equity over 15%
Return on equity was 21.7% over the last twelve months and averaged 20.3% over five years.
Return on capital under 10%
Return on invested capital was 9.4%, below the 10% that usually covers the cost of capital.
Return on equity above the industry
Iqvia's return on equity of 21.7% is above the Engineering, Accounting, Research, Management, and Related Services median of -10.2%.
Earnings grew over 5 years
Net income grew 37.3% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 8.1% over the last twelve months, against a 5-year average of 8.2%.
Net margin above the industry
Iqvia's net margin of 8.1% is above the Engineering, Accounting, Research, Management, and Related Services median of -53.6%.
Financial health0/6
High debt
Debt is 241% of shareholders' equity, above the 40% we consider low.
Debt rising against equity
Debt to equity rose from 209% five years ago to 241%.
Debt not well covered by cash flow
Operating cash flow over the last twelve months equals 17.0% of total debt; we look for at least 20%.
Interest not well covered
Operating income covers interest expense 2.8 times; we look for at least 5.
Short-term assets don't cover short-term debts
Current assets are 0.83 times current liabilities.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.28; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Iqvia has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$219.95
The share price is 25% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 29.0× | 32.6× | 25.2× | $238.28 | 40% |
| EV/EBITDA | 16.0× | 16.8× | 15.3× | $251.45 | 35% |
| P/B | 5.1× | 6.5× | 3.7× | $205.97 | 10% |
| Earnings power | 10.7% cost of equity | – | – | $106.90 | 15% |
| Fair value | $219.95 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 32.6
- Engineering, Accounting, Research, Management, and Related Services median 25.2
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $367.57M
- Value traded per 1% price move
- $273.87M
Downside
High risk
- Typical loss in a bad month
- 30.0%
- Volatility (annualized)
- 41%
- Sharpe ratio, 1 year
- 0.60
- Beta to the S&P 500 (5Y)
- 1.17
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +5.9% | +4.2% | +7.5% | +11.0% | |
| Gross profit | +1.0% | +2.6% | +7.1% | +6.0% | |
| Operating income | -0.9% | +6.6% | +24.4% | +12.9% | |
| Net income | -0.9% | +7.6% | +37.3% | +13.4% | |
| EPS, diluted | +4.7% | +11.1% | +40.5% | +9.8% | |
| Free cash flow | -3.0% | +8.9% | +8.8% | +17.8% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 1.8% | 4.6% | 21.6% | |
| Return on assets | 0.6% | 1.2% | 4.8% | |
| Current ratio | 1.23 | 1.12 | 0.75 | |
| Debt to equity | 0.83 | 2.09 | 2.42 | |
| Net debt to EBITDA | 6.94× | 5.31× | 4.13× | |
| Interest coverage | 4.0× | 1.8× | 3.0× | |
| Capex to revenue | 2.4% | 5.4% | 3.7% | |
| Diluted shares | 152M | 195M | 174M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Iqvia generated $12.72B from operations and spent $8.33B on capital expenditure, dividends and share buybacks. 38% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 8.3% | 0.57× | 4.52× | 21.6% |
| FY2024 | 8.9% | 0.58× | 4.40× | 22.5% |
| FY2023 | 9.1% | 0.58× | 4.38× | 22.9% |
| FY2022 | 7.6% | 0.58× | 4.24× | 18.5% |
| FY2021 | 7.0% | 0.56× | 4.09× | 16.0% |
| FY2020 | 2.5% | 0.48× | 3.98× | 4.6% |
| FY2019 | 1.7% | 0.48× | 3.60× | 3.0% |
| FY2018 | 2.5% | 0.46× | 3.09× | 3.5% |
| FY2017 | 13.2% | 0.44× | 2.65× | 15.4% |
| FY2016 | 1.1% | 0.54× | 3.11× | 1.8% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$1.36B
- Cash generatingOperating cash flow above zero$2.65B
- Return on assets improvedROA up on the prior year5.1% → 5.1%
- Earnings backed by cashOperating cash flow above net income$2.65B vs $1.36B
- Less leverageLong-term debt to assets fell47.7% → 46.4%
- Better liquidityCurrent ratio rose0.84 → 0.75
- No dilutionShare count did not rise183M → 174M
- Gross margin improvedGross margin up on the prior year34.89% → 33.29%
- More efficientAsset turnover rose0.58 → 0.61
See a number that looks wrong?